A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients
Metabolomics offers new insights into disease mechanisms that is enhanced when adopting orthogonal instrumental platforms to expand metabolome coverage, while also reducing false discoveries by independent replication. Herein, we report the first inter-method comparison when using multisegment injec...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021-08-01
|
| Серии: | Frontiers in Molecular Biosciences |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.676349/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|